Reply to thread

Message: <blockquote data-quote="user2024" data-source="post: 30485747" data-attributes="member: 585832"><a href="https://www.themorning.lk/articles/JRhAcuAK2qPpiNpmqNPW" target="_blank">https://www.themorning.lk/articles/JRhAcuAK2qPpiNpmqNPW</a> (22 Sep 2024)The papaverine caseIn 2021, the MSD had purchased 1,560 units of papaverine hydrochloride injections, a medicine used primarily in cardiothoracic treatments, at a staggering cost of Rs. 68.59 million. The issue? The unit price of Rs. 40,868.98 was grossly inflated compared to the estimated price of Rs. 255.07. Despite the exorbitant bid, the Procurement Committee had approved the purchase without calling for new quotations, resulting in an even larger order of 3,125 units at a total cost of Rs. 127.72 million.This wasn’t just a financial oversight; procedural lapses exacerbated the situation. According to procurement guidelines, any tender exceeding Rs. 50 million should be evaluated by a Technical Evaluation Committee (TEC) consisting of five members. However, in this case, only three members were appointed, violating standard regulations.Moreover, the MSD had explicitly instructed that the order should consider existing stock levels before opening Letters of Credit (LCs). These instructions had been ignored, and instead of opening LCs for only 40% of the required quantity, as per the annual demand for the medicine, LCs had been opened for 1,563 units. By August 2022, 1,421 units remained unused, with many set to expire by February 2023.මේ case එක නම්  කාලෙකට කලින් හෙන ප්‍රසිද්ද උනා </blockquote>

Verification: Awruddata maasa keeyada?

Top Bottom